top of page
Search

Extracellular Communication




Mercury Bio has harnessed the power of extracellular communication via the creation of a yeast-derived, highly targeted drug delivery platform that unleashes the potential for new medicines and vaccines to treat previously untreatable diseases and accelerate healing. Our 2021 & 2024 Technology & Manufacturing (TEAM) Fund awards helped Mercury Bio/Spartina Biotechnologies in its pre-patent days to its current expansion and commercialization. Here’s to Mercury Bio becoming a million-dollar—billion-dollar—company!


For more information on the Regional Development Corporation (RDC) Technology & Manufacturing (TEAM) Fund: https://www.rdcnm.org/team-fund



コメント


© Regional Development Corporation                           info@rdcnm.org

bottom of page